Annual Cash & Cash Equivalents
$286.33 M
+$258.32 M+922.48%
31 December 2023
Summary:
Mirum Pharmaceuticals annual cash & cash equivalents is currently $286.33 million, with the most recent change of +$258.32 million (+922.48%) on 31 December 2023. During the last 3 years, it has risen by +$254.99 million (+813.61%). MIRM annual cash & cash equivalents is now at all-time high.MIRM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$222.97 M
-$10.28 M-4.41%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly cash and cash equivalents is currently $222.97 million, with the most recent change of -$10.28 million (-4.41%) on 30 September 2024. Over the past year, it has dropped by -$63.36 million (-22.13%). MIRM quarterly cash and cash equivalents is now -26.43% below its all-time high of $303.06 million, reached on 30 September 2023.MIRM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -22.1% |
| 3 y3 years | +813.6% | +611.5% |
| 5 y5 years | +2292.0% | +1762.7% |
MIRM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +922.5% | -26.4% | +696.2% |
| 5 y | 5 years | at high | +2292.0% | -26.4% | +1762.7% |
| alltime | all time | at high | +2292.0% | -26.4% | +1762.7% |
Mirum Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $222.97 M(-4.4%) |
| June 2024 | - | $233.25 M(-23.0%) |
| Mar 2024 | - | $302.84 M(+5.8%) |
| Dec 2023 | $286.33 M(+922.5%) | $286.33 M(-5.5%) |
| Sept 2023 | - | $303.06 M(+2.0%) |
| June 2023 | - | $297.23 M(+501.4%) |
| Mar 2023 | - | $49.42 M(+76.5%) |
| Dec 2022 | $28.00 M(-10.6%) | $28.00 M(-21.7%) |
| Sept 2022 | - | $35.76 M(-35.3%) |
| June 2022 | - | $55.27 M(+19.4%) |
| Mar 2022 | - | $46.27 M(+47.6%) |
| Dec 2021 | $31.34 M | $31.34 M(-43.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $55.84 M(-39.3%) |
| June 2021 | - | $91.94 M(+1.4%) |
| Mar 2021 | - | $90.68 M(-36.2%) |
| Dec 2020 | $142.09 M(+1087.0%) | $142.09 M(+191.3%) |
| Sept 2020 | - | $48.78 M(-41.3%) |
| June 2020 | - | $83.04 M(+15.3%) |
| Mar 2020 | - | $72.03 M(+501.8%) |
| Dec 2019 | $11.97 M(-77.0%) | $11.97 M(-61.2%) |
| Sept 2019 | - | $30.81 M(-26.3%) |
| June 2019 | - | $41.82 M(-15.5%) |
| Mar 2019 | - | $49.49 M |
| Dec 2018 | $51.96 M | - |
FAQ
- What is Mirum Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Mirum Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of MIRM is $286.33 M
What is the all time high annual cash & cash equivalents for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual cash & cash equivalents is $286.33 M
What is Mirum Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MIRM is $222.97 M
What is the all time high quarterly cash and cash equivalents for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly cash and cash equivalents is $303.06 M
What is Mirum Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, MIRM quarterly cash and cash equivalents has changed by -$63.36 M (-22.13%)